| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Par Value |
500 | 500 | 500 | 500 |
| Yearly Highest Price |
4,480 | 4,200 | 9,110 | 6,840 |
| Yearly Lowest Price |
3,030 | 2,210 | 2,430 | 5,380 |
| Common Shares O/S |
15,025,924 | 15,025,924 | 15,025,924 | 15,025,924 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
491 | 365 | 1,005 | 862 |
| Dividends (%) |
10.0 | 12.0 | 15.0 | - |
|
 |
(Company/Sector/Market) |
| |
2009.06 | 2010.06 |
| Beta |
0.71 / 0.54 / 1.00 | 0.36 / 0.55 / 1.00 |
| Volatility |
61.49 / 32.47 / 41.28 | 32.81 / 20.53 / 17.70 |
|
 |
(unit : Won) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Earnings Per Share |
380 | 603 | 951 | 1,190 |
| Sales Per Share |
4,065 | 6,434 | 7,977 | 8,902 |
| Book Value Per Share |
2,913 | 3,512 | 5,199 | 5,883 |
| Cash Flow Per Share |
231.77 | 479.20 | 1,245.48 | 1,044.71 |
|
 |
(Unit : Times) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Price / Earnings (H/L) |
11.79/7.97 | 6.97/3.67 | 9.58/2.56 | 5.74/4.52 |
| Price / Sales (H/L) |
1.10/0.75 | 0.65/0.34 | 1.14/0.30 | 0.77/0.60 |
| Price / Book (H/L) |
1.54/1.04 | 1.20/0.63 | 1.75/0.47 | 1.16/0.91 |
| Price / Cash Flow (H/L) |
19.33 / 13.07 | 8.76 / 4.61 | 7.31 / 1.95 | 6.55 / 5.15 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
07.03 |
07.12 |
08.12 |
09.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
509 |
708 |
529 |
708 |
594 |
940 |
739 |
1,048 |
| NOPLAT |
66 |
60 |
56 |
60 |
107 |
70 |
140 |
143 |
| Return on Invested Capital |
13 |
8 |
10 |
8 |
18 |
7 |
19 |
13 |
| WACC |
6 |
6 |
5 |
6 |
6 |
6 |
5 |
6 |
| Economic Value Added |
31.5 |
10.9 |
24.6 |
10.9 |
68.0 |
5.3 |
99.0 |
75.1 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2007.12 | 2008.12 | 2009.12 | 2010.09 |
| Enterprise Value(EV) |
648.14 | 494.03 | 1,123.00 | 981.48 |
| EBITDA |
96.86 | 159.30 | 231.87 | 264.32 |
| EBITDA/Sales |
0.16 | 0.17 | 0.19 | 0.20 |
| EBITDA/Financial Exp. |
7.41 | 8.51 | 15.02 | 18.88 |
| EV/EBITDA |
6.69 | 3.10 | 4.84 | 3.71 |
|
|
|
|
